Erich Studerus

ORCID: 0000-0003-4233-0182
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Functional Brain Connectivity Studies
  • Mental Health and Psychiatry
  • Mental Health Research Topics
  • Bipolar Disorder and Treatment
  • Advanced Neuroimaging Techniques and Applications
  • Tryptophan and brain disorders
  • Psychedelics and Drug Studies
  • Neural dynamics and brain function
  • Child and Adolescent Psychosocial and Emotional Development
  • Cannabis and Cannabinoid Research
  • Obsessive-Compulsive Spectrum Disorders
  • Neurotransmitter Receptor Influence on Behavior
  • EEG and Brain-Computer Interfaces
  • Mental Health Treatment and Access
  • Neural and Behavioral Psychology Studies
  • Forensic Toxicology and Drug Analysis
  • Treatment of Major Depression
  • Psychosomatic Disorders and Their Treatments
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Attention Deficit Hyperactivity Disorder
  • Neuroscience and Music Perception
  • Advanced MRI Techniques and Applications
  • Health, Environment, Cognitive Aging
  • Chemical synthesis and alkaloids

University of Basel
2016-2025

FHNW University of Applied Sciences and Arts
2024

University of Bologna
2020

Technical University of Munich
2020

Universitäre Psychiatrische Kliniken Basel
2012-2016

Ludwig-Maximilians-Universität München
2016

Gender Studies
2016

University of Zurich
2012-2014

University Hospital of Basel
2012-2013

University Hospital of Zurich
2008-2011

Background The OAV questionnaire has been developed to integrate research on altered states of consciousness (ASC). It measures three primary and one secondary dimensions ASC that are hypothesized be invariant across induction methods. rating scale in use for more than 20 years applied internationally a broad range fields, yet its factorial structure never tested by structural equation modeling techniques psychometric properties have examined large samples experimentally induced ASC....

10.1371/journal.pone.0012412 article EN cc-by PLoS ONE 2010-08-31

Psilocybin and related hallucinogenic compounds are increasingly used in human research. However, due to limited information about potential subjective side effects, the controlled medical use of these has remained controversial. We therefore analysed acute, short- long-term effects psilocybin healthy humans by pooling raw data from eight double-blind placebo-controlled experimental studies conducted between 1999 2008. The analysis included 110 subjects who had received 1–4 oral doses...

10.1177/0269881110382466 article EN Journal of Psychopharmacology 2010-09-20

Responses to hallucinogenic drugs, such as psilocybin, are believed be critically dependent on the user's personality, current mood state, drug pre-experiences, expectancies, and social environmental variables. However, little is known about order of importance these variables their effect sizes in comparison dose. Hence, this study investigated effects 24 predictor variables, including age, sex, education, personality traits, pre-experience, mental state before intake, experimental setting,...

10.1371/journal.pone.0030800 article EN cc-by PLoS ONE 2012-02-17

To date, the MRI-based individualized prediction of psychosis has only been demonstrated in single-site studies. It remains unclear if MRI biomarkers generalize across different centers and MR scanners represent accurate surrogates risk for developing this devastating illness. Therefore, we assessed whether a system identified patients with later disease transition among 73 clinically defined high-risk persons recruited at two early recognition centers. Prognostic performance was measured...

10.1093/schbul/sbu078 article EN Schizophrenia Bulletin 2014-06-09

Adverse childhood experiences (ACEs) are common in people at clinical high-risk for psychosis (CHR), however, the relationship between ACEs and long-term outcomes is still unclear. This study examined associations CHR individuals. 344 individuals 67 healthy controls (HC) were assessed using Childhood Trauma Questionnaire (CTQ), Bullying Experience of Care Abuse (CECA). followed up to 5 years. Remission from state, transition (both defined with Comprehensive Assessment an At Risk Mental...

10.1038/s41537-025-00562-9 article EN cc-by Schizophrenia 2025-02-20

Converging evidence indicates that neural oscillations coordinate activity across brain areas, a process which is seemingly perturbed in schizophrenia. In particular, beta (13-30 Hz) and gamma (30-50 were repeatedly found to be disturbed schizophrenia linked clinical symptoms. However, it remains unknown whether abnormalities current source density (CSD) lagged phase synchronization of distributed regions the already occur patients with an at-risk mental state (ARMS) for psychosis.To further...

10.1093/schbul/sbu134 article EN Schizophrenia Bulletin 2014-09-09

BackgroundA key clinical challenge in the management of individuals at high risk for psychosis (CHR) is that it difficult to predict their future outcomes. Here, we investigated if levels circulating molecular lipids are related adverse outcomes this group.MethodsSerum lipidomic analysis was performed 263 CHR and 51 healthy control subjects, who were then clinically monitored up 5 years. Machine learning used identify lipid profiles discriminated between subgroups subjects with distinct...

10.1016/j.biopsych.2020.07.012 article EN cc-by-nc-nd Biological Psychiatry 2020-07-25

Background: The at-risk mental state for psychosis (ARMS) and the first episode of have been associated with structural brain abnormalities that could aid in individualized early recognition psychosis. However, it is unknown whether development these alterations predates clinical deterioration individuals, or alternatively, parallels transition to at single-subject level. Methods: We evaluated performance an magnetic resonance imaging (MRI)-based classification system classifying disease...

10.1093/schbul/sbs095 article EN Schizophrenia Bulletin 2012-09-11

Objectives: Brain-derived neurotrophic factor (BDNF) is involved in numerous cognitive processes. Since deficits are a core feature of psychotic disorders, the investigation BDNF levels psychosis and their correlation with cognition has received increased attention. However, there no studies investigating individuals an at-risk mental state (ARMS) for psychosis. Hence, aims present study were: (1) assessing peripheral across different (potential) stages psychosis; (2) association...

10.1080/15622975.2018.1462532 article EN The World Journal of Biological Psychiatry 2018-06-25
David Popovic Anne Ruef Dominic Dwyer Linda A. Antonucci Julia Eder and 95 more Rachele Sanfelici Lana Kambeitz‐Ilankovic Omer Faruk Oztuerk Mark Sen Dong Riya Paul Marco Paolini Dennis M. Hedderich Theresa Haidl Joseph Kambeitz Stephan Ruhrmann Katharine Chisholm Frauke Schultze‐Lutter Peter Falkai Giulio Pergola Giuseppe Blasi Alessandro Bertolino Rebekka Lencer Udo Dannlowski Rachel Upthegrove Raimo K. R. Salokangas Christos Pantelis Eva Meisenzahl Stephen J. Wood Paolo Brambilla Stefan Borgwardt Nikolaos Koutsouleris Mark Sen Dong Anne Erkens Eva Gussmann Shalaila S. Haas Alkomiet Hasan Claudius Hoff Ifrah Khanyaree Aylin Melo Susanna Muckenhuber-Sternbauer Janis Köhler Ömer Öztürk Nora Penzel Adrian Rangnick Sebastian von Saldern Rachele Sanfelici Moritz Spangemacher Ana Tupac María Fernanda Urquijo Johanna Weiske Julian Wenzel Antonia Wosgien Linda T. Betz Karsten Blume Mauro Seves Nathalie Kaiser Thorsten Lichtenstein Christiane Woopen Christina Andreou Laura Egloff Fabienne Harrisberger Claudia Lenz Letizia Leanza Amatya Mackintosh Renata Smieskova Erich Studerus Anna Walter Sonja Widmayer Chris Day Siân Lowri Griffiths Mariam Iqbal Mirabel Pelton Pavan Mallikarjun Alexandra Stainton Ashleigh Lin Alexander Denissoff Anu Ellilä Tiina From Markus Heinimaa Tuula Ilonen Päivi Jalo Heikki Laurikainen Maarit Lehtinen Antti Luutonen Akseli Mäkela Janina Paju Henri Pesonen Reetta-Liina Säilä Elina Sormunen Anna Toivonen Otto Turtonen Ana Beatriz Solana Manuela Abraham Nicolas Hehn Timo Schirmer Carlo Altamura Marika Belleri Francesca Bottinelli Adele Ferro Marta Re

10.1016/j.biopsych.2020.05.020 article EN Biological Psychiatry 2020-05-26

Background: 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) is used both recreationally and therapeutically. Little known about the factors influencing inter- intra-individual differences in acute response to MDMA. Effects of other psychoactive substances have been shown be critically influenced by personality traits mood state before intake. Methods: We pooled data from 10 randomized, double-blind, placebo-controlled, cross-over studies performed same laboratory 194 healthy subjects...

10.1177/0269881121998322 article EN cc-by-nc Journal of Psychopharmacology 2021-03-30
Eva Velthorst Josephine Mollon Robin M. Murray Lieuwe de Haan Inez Myin‐Germeys and 95 more David C. Glahn Celso Arango E. van der Ven Marta Di Forti Miquel Bernardo Sinan Gülöksüz Philippe Delespaul Gisela Mezquida Sílvia Amoretti Julio Bobes Pilar A. Sáiz María Paz García‐Portilla José Luis Santos Estela Jiménez‐López Julio Sanjuán Eduardo J. Aguilar Manuel Arrojo Ángel Carracedo Gonzalo López Javier González‐Peñas Mara Parellada Cem Atbaşoğlu Meram Can Saka Alp Üçok Köksal Alptekın Berna Binnur Akdede Tolga Binbay Vesile Altınyazar Halis Ulaş Berna Yalınçetin Güvem Gümüş‐Akay Burçin Cihan Beyaz Haldun Soygür Eylem Şahin Cankurtaran Semra Ulusoy Kaymak Nadja P. Marić Marina Mihaljević Sanja Andrić Petrović Tijana Mirjanic Cristina Marta Del‐Ben Laura Ferraro Charlotte Gayer‐Anderson Peter B. Jones Hannah E. Jongsma James B. Kirkbride Caterina La Cascia Antonio Lasalvia Sarah Tosato Pierre‐Michel Llorca Paulo Rossi Menezes Craig Morgan Diego Quattrone Marco Menchetti Jean‐Paul Selten Andreı̈ Szöke Ilaria Tarricone Andrea Tortelli Philip McGuire Lucia Valmaggia Matthew J. Kempton Mark van der Gaag Anita Riecher‐Rössler Rodrigo A. Bressan Neus Barrantes‐Vidal Barnaby Nelson Patrick D. McGorry Christos Pantelis Marie‐Odile Krebs Stephan Ruhrmann Gabriele Sachs Bart P. F. Rutten Jim van Os Behrooz Z. Alizadeh Thérèse van Amelsvoort Agna A. Bartels‐Velthuis Richard Bruggeman Nico J. van Beveren Jurjen J. Luykx Wiepke Cahn Claudia J.P. Simons René S. Kahn Frederike Schirmbeck Ruud van Winkel Maria Calem Stefania Tognin Gemma Modinos Sara Pisani Tamar Kraan Daniëlla S. van Dam Nadine Burger G. Paul Amminger Athena Politis Joanne Goodall Stefan Borgwardt Erich Studerus

10.1038/s41380-020-00969-z article EN Molecular Psychiatry 2021-01-07
Nikolaos Koutsouleris Christos Pantelis Dennis Velakoulis Philip McGuire Dominic Dwyer and 95 more Maria-Fernanda Urquijo-Castro Riya Paul Sen Dong David Popovic Oemer Faruk Oeztuerk Joseph Kambeitz Raimo K. R. Salokangas Jarmo Hietala Alessandro Bertolino Paolo Brambilla Rachel Upthegrove Stephen J. Wood Rebekka Lencer Stefan Borgwardt Carlo Maj Markus M. Nöthen Franziska Degenhardt Maryna Polyakova Karsten Mueller Arno Villringer Adrian Danek Klaus Faßbender Klaus Fließbach Holger Jahn Johannes Kornhuber G. Bernhard Landwehrmeyer Sarah Anderl‐Straub Johannes Prudlo Matthis Synofzik Jens Wiltfang Lina Riedl Janine Diehl‐Schmid Markus Otto Eva Meisenzahl Peter Falkai Matthias L. Schroeter Shalaila S. Haas Alkomiet Hasan Claudius Hoff Ifrah Khanyaree Aylin Melo Susanna Muckenhuber-Sternbauer Yanis Köhler Ömer Öztürk Nora Penzel Adrian Rangnick Sebastian von Saldern Moritz Spangemacher Ana Tupac Johanna Weiske Antonia Wosgien Camilla Krämer Karsten Blume Dennis M. Hedderich Dominika Julkowski Nathalie Kaiser Thorsten Lichtenstein Ruth Milz Alexandra Nikolaides Tanja Pilgram Mauro Seves Martina Wassen Christina Andreou Laura Egloff Fabienne Harrisberger Ulrike Heitz Claudia Lenz Letizia Leanza Amatya Mackintosh Renata Smieskova Erich Studerus Anna Walter Sonja Widmayer Chris Day Siân Lowri Griffiths Mariam Iqbal Mirabel Pelton Pavan Mallikarjun Alexandra Stainton Ashleigh Lin Paris Alexandros Lalousis Alexander Denissoff Anu Ellilä Tiina From Markus Heinimaa Tuula Ilonen Päivi Jalo Heikki Laurikainen Antti Luutonen Akseli Mäkela Janina Paju Henri Pesonen Reetta-Liina Säilä Anna Toivonen Otto Turtonen

<h3>Importance</h3> The behavioral and cognitive symptoms of severe psychotic disorders overlap with those seen in dementia. However, shared brain alterations remain disputed, their relevance for patients at-risk disease stages has not been explored so far. <h3>Objective</h3> To use machine learning to compare the expression structural magnetic resonance imaging (MRI) patterns behavioral-variant frontotemporal dementia (bvFTD), Alzheimer (AD), schizophrenia; estimate predictability bvFTD...

10.1001/jamapsychiatry.2022.2075 article EN cc-by JAMA Psychiatry 2022-08-03

Abstract Background: Several sex differences in schizophrenia have been reported including cognitive functioning. Studies with patients and healthy controls (HC) indicate that the advantage for women verbal domains is also present patients. However, findings inconsistent. No study focused on sex-related performance at-risk mental state psychosis (ARMS) individuals yet. Thus, aim of was to investigate functioning ARMS, first episode (FEP) HC subjects. We expected a better learning memory all...

10.1016/j.eurpsy.2014.11.006 article EN European Psychiatry 2014-12-30
Coming Soon ...